Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-145801
Filing Date
2016-10-13
Accepted
2016-10-13 16:27:33
Documents
1
Period of Report
2016-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3984
  Complete submission text file 0001209191-16-145801.txt   5569
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARCADIA BIOSCIENCES, INC. 202 COUSTEAU PLACE, SUITE 105 DAVIS CA 95618
Business Address
O'Neil Thomas P. (Reporting) CIK: 0001640645 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 161935212